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Abstract: Background: Oral cancer has a profound impact on quality of life, but the relationship between quality 
of life and tumorigenesis, catecholamine levels, and disease stage in oral cancer patients is not well understood. 
Methods: Pre-surgical quality of life was determined using the Short Form 36 (SF-36) health-related quality of life 
questionnaire in 75 oral neoplasm patients, including 40 oral carcinoma patients and 35 benign oral tumor pa-
tients. The plasma epinephrine and norepinephrine concentrations were assessed using high performance liquid 
chromatography-mass spectrometry-mass spectrometry, and data were analyzed using multivariate logistic regres-
sion models. Results: There were significant differences in pain, general health, and mental health SF-36 subscores 
between the oral carcinoma and benign oral tumor groups. Multivariate logistic regression models showed that the 
SF-36 scores in the oral carcinoma group were significantly lower than those in the benign oral tumor group. Conclu-
sions: These findings show that general health is affected in oral neoplasm patients and stress hormones can affect 
quality of life in oral carcinoma patients; furthermore, plasma catecholamines and mental health contribute to the 
progression of oral carcinoma. 
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Introduction
The annual global incidence of head and neck 
carcinoma is greater than 600,000, represent-
ing the sixth most common type of cancer in 
the general population [1]. head and neck 
squamous cell carcinoma (HNSCC) comprises 
more than 90% of head and neck cnacer cases; 
moreover, there is evidence that the incidence 
is increasing [2]. Approximately two-third of 
patients suffer with dvanced stage disease 
(stages III and IV), while the remaining patients 
present with early stage disease (stages I and 
II) (stages III and IV) [3]. With advanced stages, 
the 5-year survival rate is < 50%, and survival is 
associated with considerable esthetic and 
functional problems following treatment [4, 5]. 
There is sufficient scientific evidence to sug-
gest that HNSCC is largely related to lifestyle 
[6]. Changes in hormonal and immune status 
reportedly result from chronic stress, and other 
behavioral conditions might influence the 
development and progression of carcinoma [7]. 
Chronic stress is related toabnormality of the 
neuroendocrine system, with a secondary lev-
els of catechalamine, mainly including norepi-
nephrine (NE) and epinephrine (E) [8]. NE and E 
are catecholamines released from the adrenal 
medulla and neurons of the sympathetic ner-
vous system [9]. Stress plays crucial roles in 
altering immunological and neurochemical 
functions, yet its role in cancer development 
and progression remains unclear.
The growth and progression of ovarian cancers 
might be influenced by increased noradrenergic 
responses [8], and intra-tumoral catechol-
amines such as NE increased with stress in an 
animal model; however, little is known about 
the change of tumor NE with disease grade or 
stage and tumor biological behavior in patients 
[10]. Available research suggests that circulat-
ing plasma NE concentrations are correlated 
with tumor grade and stage [11]. Some studies 
have implications from outcomes of ovarian 
cancer, indicating that beta-adrenergic signal-
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ing is associated with key biological behaviors 
involved in cancer progression [12]. In a previ-
ous study, we found that the circulating stress 
hormones including catecholamines and gluco-
corticoid might impact the biological behavior 
of oral cancer by influencing the tumor microen-
vironment [11]; however, the association 
between quality of life (QoL) and stress-related 
hormones in primary oral neoplasm patients 
was not clear. Moreover, the relationship 
between general and mental health and tumor-
igenesis in HNSCC is less clear.
Oral carcinomas can significantly affect both 
the structure and function of head and neck 
region [13], especially in terms of swallowing, 
breathing, and speaking [14]. This could lead to 
a significant reduction in QoL and impair the 
functional capacity [15, 16]. 
In this study, the association between quality of 
life and stressor catecholamines in primary 
oral neoplasm patients was analysed. It was 
hypothesized that advanced stage HNSCC 
would be associated with higher circulating 




This study was conducted according to the 
guidelines in the Declaration of Helsinki and 
and approved by the Ethics Committee of the 
West China Hospital of Stomatology (Protocol 
No: WCHSIRB-D-2013-054). All participants in 
this study signed the written informed consents 
voluntarily.
Participants
The participants consisted of 75 patients > 18 
years of age with a histological diagnosis of an 
oral neoplasm (49 men and 26 women). 
Inclusion was that primary oral neoplasms 
confirmed by pathologic diagnosis. Patients 
with metastatic lesions, systemic diseases, a 
history of alcohol abuse, or the use of drugs 
altering the immune response such as system-
ic corticosteroids or beta-blockers within the 
last 6 months were excluded. All tumor samples 
of included patients were verified by two pathol-
ogists who classified the tumors and judged 
the oral cancer stages according to TNM clas-
sification of UICC 2002. Two pathologists inde-
pendently carried out the classification of 
tumours and oral cancer stages. Disagreements 
between the 2 pathologists were discussed 
with a third pathologist for consensus. 
Quality of life, demographic, and medical as-
sessments
During the pre-operative appointment, the 
Short Form 36 (SF-36) was completed to 
assess QoL [17], which is a 36-item question-
naire that scores physical function as well as 
social and mental wellbeing within 8 domains: 
physical functioning (PF, 10 questions), role 
limitations due to physical health problems (RP, 
4 questions), bodily pain (BP, 2 questions), gen-
eral health perceptions (GH, 5 questions), men-
tal health (MH, 5 questions), role limitations 
due to emotional problems (RE, 3 questions), 
social functioning (SF, 2 questions), and vitality 
(VT, 4 questions). In addition, a question is 
included to record changes in health (HC, 1 
question) [18]. The summary scores for the 
physical and mental components were also cal-
culated. The SF-36 was translated into the 
Chinese language for the purposes of this 
study. Using the SF-36, Lam et al. and Lee et al. 
reported a high prevalence of clinical anxiety, 
depression, and severe impairment in QoL in a 
population of Chinese patients with chronic 
non-cancer pain, indicating that the SF-36 is a 
valid method to determine the QoL of Chinese 
patients [15, 16].
Blood samples were collected approximately 2 
hours before surgery, and demographic, health 
behavior, clinical, and histopathological data 
were obtained from medical records. Detailed 
information on hours of sleep, smoking, alcohol 
intake, and caffeine intake during the 7 days 
immediately preceding surgery was also 
collected.
Measurement of catecholamines
High performance liquid chromatography with 
mass spectrometry (HPLC-MS/MS) was used 
to measure blood samples, as described previ-
ously [11, 19]. Briefly, blood samples were col-
lected and stored at -80°C after centrifuging 
10 minutes at 4°C at 1,000 g using a cold 
chilled EDTA Vacutainer tubes (BD Biosciences, 
Franklin Lakes, NJ). The supernatants were 
introduced in the HPLC-MS-MS system, as pre-
viously described [11]. Sample analysis was 
carried out using an UltiMate 3000 HPLC sys-
tem (Dionex Corporation, Sunnyvale, CA). The 
eluents applied in sequence a 3200 Q TRAP 
tandem mass spectrometer (Applied Biosys- 
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tems, Foster City, CA) operated in the electro-
spray positive mode and with multiple reaction 
monitoring (MRM). 
Statistical analyses
The data were analysed with SPSS version 19.0 
(IBM Corp., Armonk, NY). Catecholamine con-
centrations in each compartment were exam-
ined using Pearson’s correlation coefficients. 
Either Chi-squared tests or analyses of vari-
ance (ANOVA) were used to test categorical 
variables. Following the detection of a possible 
tumorigenesis effect in any of the SF-36 indi-
ces, the mean scores of the SF-36 scales were 
compared using ANOVA, based on the two dif-
ferent diagnostic subgroups of oral cancer and 
oral benign tumor. To better understand the dif-
ferences in catecholamines and QoL based on 
tumorigenesis, bivariate associations between 
each of the domain scales and catecholamine 
concentrations were assessed using logistic 
regression models, which estimated the odds 
ratios (OR) with 95% confidence intervals (CI) 
[20]. Statistically significance was determined 
by a P-value < 0.05.
Results
Participant characteristics
There were no significant differences in age, 
gender, tumor location, income, marital status, 
or educational status between the benign 
tumor and carcinoma groups. There were no 
significant correlations in catecholamine con-
centrations in any compartment (P > 0.34). 
er than in the benign tumor group (49.48 ± 
31.04 pg/mL, E; 252.14 ± 81.80 pg/mL, NE; P 
< 0. 01).
Peripheral blood catecholamine levels were sig-
nificantly different based on cancer stage, with 
lower concentrations in stages I and II (early 
stage) cancer (56.61 ± 23.09 pg/mL, E; 
267.81± 89.77 pg/mL, NE) than in stages III 
and IV (advanced stage) cancer (88.75 ± 39.20 
pg/mL, E; 382.91 ± 99.50 pg/mL, NE; P < 
0.05) (Table 2).
Biobehavioral factors and catecholamines 
In the bivariate analyses, only one SF-36 
domain (GH) was significantly associated with 
tumorigenesis in oral neoplasm patients, indi-
cating that better general health (OR 0.54, 95% 
CI 0.319-0.917) was associated with the lack 
of an oral tumor (Table 3). 
There was also a difference in plasma E (OR 
1.478, 95% CI 1.117-1.901, P = 0.0028) and 
plasma NE (OR 1.521, 95% CI 1.275-2.102, P = 
0.075) levels based on carcinoma stage (Table 
4). The combined estimate showed no differ-
ence in SF-36 based on carcinoma stage 
except for the BP (OR 0.995, 95% CI 0.694-
1.427, P = 0.045) and MH (OR 1.304, 95% CI 
1.012-2.014, P = 0.036) domains.
Discussion
In the present study, blood catecholamine lev-
els in patients with primary oral cancer were 
Table 1. Comparison of SF-36 scores between the oral 
cancer and benign oral tumor groups
SF-36 Benign Tumor Group (n = 35)
Carcinoma 
Group (n = 40) Z* P
PF 29.4 ± 1.03 27.6 ± 2.46 4.34 < 0.01
RP 7.74 ± 0.61 6.40 ± 1.34 4.88 < 0.01
BP 4.34 ± 2.13 5.03 ± 1.73 -1.93 0.0436
GH 14.89 ± 1.66 15.90 ± 1.63 -2.42 0.0157
VT 13.86 ± 2.91 13.40 ± 2.45 0.49 0.6255
SF 6.71 ± 1.32 6.28 ± 1.40 1.33 0.1844
RE 5.83 ± 0.62 4.80 ± 1.26 4.03 < 0.01
MH 18.23 ± 2.34 17.65 ± 3.17 -0.89 0.3770
HC 3.20 ± 0.68 3.63 ± 0.81 -2.07 0.0387
TOTAL 104.20 ± 7.17 100.68 ± 7.22 -2.12 0.038
Values are reported as mean ± standard deviation. BP, bodily pain; 
HC, health change; GH, general health; MH, mental health; PF, 
physical functioning; RE, role emotional; RP, role physical; SF, social 
functioning; VT, vitality.
Those 40 oral cancer tissue cases collect-
ed from head and neck ward of West China 
hospital of Stomatology, according to TNM 
classification of UICC 2002, 4 cases of 
stage I, 19 cases of stage II , 10 cases of 
stage III and 7 cases of stage IV.
SF-36 domains
There were significant differences between 
the two groups in most of the SF-36 
domain scores (PF, P < 0.001; RP, P < 
0.001; BP, P = 0.0436; GH, P = 0.0157; 
RE, P < 0.001; and HC, P = 0.0387) (Table 
1).
Catecholamines and tumor histology
The mean catecholamine concentrations 
in peripheral blood in the carcinoma group 
(70.27 ± 34.50 pg/mL, E; 316.73 ± 
109.22 pg/mL, NE) were significantly high-
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related with both disease severity and QoL. 
General health might be particularly affected in 
and oral cancer, which is consistent with the 
findings of others [10] and suggests that 
Table 2. Comparison of the concentration of catecholamine in plasma of peripheral blood between 
oral cancer and benign oral tumor patients
Plasma E (pg/ml) Plasma NE (pg/ml)
Mean ± Sd t p Mean ± Sd t P
Tumor Type Benign (N = 35) 49.48±31.04 -2.97 0.0030 252.14 ± 81.80 -2.89 0.0039
Cancer (N = 40) 70.27 ± 34.50 316.73 ± 109.22
Cancer Stage Early (N = 23) 56.60 ± 23.09 -3.02 0.006 267.81 ± 89.77 -3.83 0.0005
Advanced (N = 17) 88.75 ± 39.20 382.91 ± 99.50
Table 3. Bivariate associations between quality of life and plasma catecholamine levels in peripheral 
blood and oral tumorigenesis in oral neoplasm patients (n = 75)
Variable Estimate Standard Wald P OR 95% CI
SF-36 PF 0.1652 0.1759 0.8811 0.3479 1.18 0.836-1.665
SF-36 RP 0.3172 0.3853 0.6781 0.4102 1.373 0.645-2.922
SF-36 BP -0.0259 0.1865 0.0192 0.8897 0.974 0.676-1.404
SF-36 GH -0.6154 0.2697 5.205 0.0225 0.54 0.319-0.917
SF-36 VT 0.2338 0.1521 2.3622 0.1243 1.263 0.938-1.702
SF-36 SF -0.0528 0.2755 0.0367 0.8481 0.949 0.553-1.628
SF-36 RE 0.2872 0.4286 0.4492 0.5027 1.333 0.575-3.087
SF-36 MH 0.1266 0.1362 0.8627 0.353 1.135 0.869-1.482
SF-36 HC -1.0891 0.5782 3.5479 0.0596 0.337 0.108-1.045
SF-36 Total -0.011 0.0538 0.0419 0.8378 0.989 0.89-1.099
Plasma E (pg/mL) -0.0428 0.0222 3.7362 0.0532 0.958 0.917-1.001
Plasma NE (pg/mL) -0.0126 0.00644 3.8211 0.0506 0.987 0.975-1
OR, odds ratio; CI, confidence interval; E, epinephrine; NE, norepinephrine; BP, bodily pain; HC, health change; GH, general 
health; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality.
Table 4. Bivariate associations between quality of life and plasma cat-
echolamine levels in peripheral blood and oral carcinoma progression 
(stage) in oral carcinoma patients (n = 40)
Variable Estimate Standard Wald P OR 95% CI
SF-36 PF 0.036 0.1577 0.052 0.8195 1.037 0.761-1.412
SF-36 RP -0.5771 0.3989 2.093 0.148 0.562 0.257-1.227
SF-36 BP -0.3626 0.2881 1.5838 0.0451 0.995 0.694-1.427
SF-36 GH -0.0284 0.2452 0.0134 0.9077 0.972 0.601-1.572
SF-36 VT -0.2864 0.2197 1.6993 0.1924 0.751 0.488-1.155
SF-36 SF -0.3508 0.3512 0.9979 0.3178 0.704 0.354-1.401
SF-36 RE 0.4568 0.3566 1.6407 0.2002 1.579 0.785-3.176
SF-36 MH 0.1978 0.179 1.2205 0.0351 1.304 1.012-2.014
SF-36 HC 0.0489 0.4988 0.0096 0.9219 1.05 0.395-2.792
SF-36 Total 0.0235 0.0459 0.2629 0.2804 1.024 0.940-1.118
Plasma E (pg/mL) -0.022 0.0135 2.6612 0.0028 1.478 1.117-1.901
Plasma NE (pg/mL) -0.0104 0.00388 7.1543 0.0075 1.521 1.275-2.102
OR, odds ratio; CI, confidence interval; E, epinephrine; NE, norepinephrine; BP, bodily pain; 
HC, health change; GH, general health; MH, mental health; PF, physical functioning; RE, role 
emotional; RP, role physical; SF, social functioning; VT, vitality.
patients with oral neo-
plasms, while patients 
with oral carcinoma ex- 
perience mental health 
issues and have higher 
catecholamine levels 
than patients with a 
benign tumor.
All of the SF-36 sub-
scale scores in the pres-
ent study were lower 
than the norm for the 
local Chinese popula-
tion with a similar age 
and sex distribution, 
indicating significant 
impairment in QoL [15, 
16]. These findings, 
determined using logit 
models, provide support 
for a link between QoL 
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patients diagnosed with oral cancer have more 
physical distress than patients diagnosed with 
a benign oral tumor. However, patients with a 
benign oral tumor reported greater mental dis-
tress and poorer subjective symptoms, includ-
ing pain, during the preoperative period. Most 
of the patients with oral cancer were not aware 
of the true nature of the disease, while patients 
with a suspected benign oral tumor were 
always aware of the disease status. The total 
SF-36 scores (OR 1.024, 95% CI 0.94-1.118, P 
= 0.2804) were not associated with carcinoma 
stage; however, the OR of plasma NE (OR 
0.987, 95% CI 0.975-1, P = 0.0506) indicated 
that this result was consistent with other 
results and the association would likely be sta-
tistically significant in a larger sample.
In our previous study, we found associations 
between biobehavioral factors, measured 
using the Symptom Checklist-90-revised 
Inventory, and circulating blood catecholamine 
and glucocorticoid levels in oral neoplasm 
patients [11]. Based upon our findings, we 
showed that chronic stress influenced key bio-
logical behaviors of oral cancinoma by chang-
ing the tumor microenvironment though the 
circulating blood plasma. Although plasma E 
and NE levels did not differ by tumorigenesis in 
the present study, the data indicate a potential 
relationship between circulating catechol-
amine levels and cancer stage. The plasma E 
and NE levels were significantly higher in 
advanced stages of oral cancer than in the 
early stages. 
Positive correlations between chronic stress 
and carcinoma progress have been emerged in 
both clinical and animal model studies. The 
locus ceruleus/norepinephrine (LC/NE) sympa-
thetic system and catecholamine mediator 
(e.g., NE and E) production are involved in the 
stress response; because these arise both 
from the sympathetic system and adrenal 
medulla, it is possible that distinct information 
is provided by circulating plasma NE concentra-
tions [21]. Chronic stress is associated with 
dysregulation of the LC/NE sympathetic sys-
tem, with a consequent increase in NE and E 
levels released from the adrenal medulla and 
the neurons of LC/NE sympathetic system to 
promote tumor growth and angiogenesis [12]. 
Carcinomas in stressed animals indicated sig-
nally increased angiogenesis and over expres-
sion of VEGF, MMP2, and MMP9 [8].
Regarding our methodology for the measure-
ment of NE and E, because NE and E rarely 
exist in peripheral blood, it is essential to deter-
mine an accurate method to precisely measure 
plasma NE and E concentrations. Because the 
HPLC-MS-MS monitors ion transitions using 
MRM, it has better specificity than LC-MS. Gu 
et al. [22] used two HPLC-MSMS methods in 
the MRM acquisition mode for quantitative 
analysis of 13 compounds in the catechol-
amine biosynthetic and metabolic pathways. 
Compared with other existing methods, the 
time-consuming sample pretreatment proce-
dure was shortened. HPLC-MS-MS methods 
are simple, rapid, reproducible, and efficient to 
determine plasma catecholamine concentra-
tions [11]. 
The findings of the present study support our 
hypothesis that patients with oral cancer have 
higher catecholamine levels in peripheral blood 
than patients with benign oral tumors. Plasma 
catecholamine levels and mental health play a 
larger role in the progression of oral carcinoma 
than oral tumorigenesis. 
Acknowledgements
The project was supported by Initial Scientific 
Research Fund of Young Teachers in West 
China Hospital of Stomatology, Sichuan 
University. We would like to thank Dr. Yousef 
Abdalla from James Cook University Australia 
for his kind assistance in improving the lan-
guage of this manuscript.
Disclosure of conflict of interest
None.
Address correspondence to: Longjiang Li, State Key 
Laboratory of Oral Diseases, West China Hospital of 
Stomatology, Sichuan University, Chengdu, China; 
West China School of Stomatology Sichuan Uni- 
versity, Chengdu 610041, Sichuan, China. E-mail: 
muzili63@163.com
References
[1] Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun 
MJ. Cancer statistics. CAA Cancer J for Clin 
2009; 59: 225-249.
[2] Saunders MI, Rojas AM, Saunders MI and Ro-
jas AM. Management of cancer of the head 
and neck-a cocktail with your PORT? N Engl J 
Med 2004; 350: 1997-1999.
Mental health affect the progression of oral carcinoma
6770 Int J Clin Exp Med 2016;9(3):6765-6770
[3] de Bree R and Leemans CR. Recent advances 
in surgery for head and neck cancer. Curr Opin 
Oncol 2010; 22: 186-193.
[4] Vokes EE. Chemotherapy and integrated treat-
ment approaches in head and neck cancer. 
Curr Opin Oncol 1991; 3: 529-534.
[5] Gleich LL, Salamone FN, Gleich LL and Sal-
amone FN. Molecular genetics of head and 
neck cancer. Cancer Control 2002; 9: 369-
378.
[6] Mignogna MD, Fedele S and Lo Russo L. The 
World Cancer Report and the burden of oral 
cancer. Eur J Cancer Prev 2004; 13: 139-142.
[7] Bernabe DG, Tamae AC, Biasoli ER, Oliveira 
SH, Bernabe DG, Tamae AC, Biasoli ER and 
Oliveira SH. Stress hormones increase cell pro-
liferation and regulates interleukin-6 secretion 
in human oral squamous cell carcinoma cells. 
Brain Behav Immun 2011; 25: 574-583.
[8] Thaker PH, Han LY, Kamat AA, Arevalo JM, 
Takahashi R, Lu C, Jennings NB, Armaiz-Pena 
G, Bankson JA, Ravoori M, Merritt WM, Lin YG, 
Mangala LS, Kim TJ, Coleman RL, Landen CN, 
Li Y, Felix E, Sanguino AM, Newman RA, Lloyd 
M, Gershenson DM, Kundra V, Lopez-Berestein 
G, Lutgendorf SK, Cole SW, Sood AK, Thaker 
PH, Han LY, Kamat AA, Arevalo JM, Takahashi 
R, Lu C, Jennings NB, Armaiz-Pena G, Bankson 
JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, 
Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, 
Sanguino AM, Newman RA, Lloyd M, Gershen-
son DM, Kundra V, Lopez-Berestein G, Lutgen-
dorf SK, Cole SW and Sood AK. Chronic stress 
promotes tumor growth and angiogenesis in a 
mouse model of ovarian carcinoma. Nat Med 
2006; 12: 939-944.
[9] Kiecolt-Glaser JK, Stephens RE, Lipetz PD, 
Speicher CE and Glaser R. Distress and DNA 
repair in human lymphocytes. J Behav Med 
1985; 8: 311-320.
[10] Lutgendorf SK, DeGeest K, Sung CY, Arevalo 
JM, Penedo F, Lucci J, Goodheart M, Lubaroff 
D, Farley DM, Sood AK and Cole SW. Depres-
sion, social support, and beta-adrenergic tran-
scription control in human ovarian cancer. 
Brain Behav Immun 2009; 23: 176-183.
[11] Xie H, Li B, Li L, Zou XL, Zhu CR, Li Y, Gao N, 
Chen Q and Li L. Association of Increased Cir-
culating Catecholamine and Glucocorticoid 
Levels with Risk of Psychological Problems in 
Oral Neoplasm Patients. PLoS One 2014; 9: 
e99179.
[12] Lutgendorf SK, DeGeest K, Dahmoush L, Far-
ley D, Penedo F, Bender D, Goodheart M, Buek-
ers TE, Mendez L, Krueger G, Clevenger L, 
Lubaroff DM, Sood AK, Cole SW, Lutgendorf 
SK, DeGeest K, Dahmoush L, Farley D, Penedo 
F, Bender D, Goodheart M, Buekers TE, Men-
dez L, Krueger G, Clevenger L, Lubaroff DM, 
Sood AK and Cole SW. Social isolation is asso-
ciated with elevated tumor norepinephrine in 
ovarian carcinoma patients. Brain Behav Im-
mun 2011; 25: 250-255.
[13] Sammut L, Ward M and Patel N. Physical activ-
ity and quality of life in head and neck cancer 
survivors: a literature review. Int J Sports Med 
2014; 35: 794-799.
[14] Rogers LQ, Courneya KS, Robbins KT, Malone 
J, Seiz A, Koch L, Rao K and Nagarkar M. Phys-
ical activity and quality of life in head and neck 
cancer survivors. Support Care Cancer 2006; 
14: 1012-1019.
[15] Lam C, Lauder I, Lam T and Gandek B. Popula-
tion based norming of the Chinese (HK) ver-
sion of the SF-36 health survey. Hong Kong 
Practitioner 1999; 21: 460-470.
[16] Lee S, Chen P, Lee A, Ma M, Wong C and Gin T. 
A prospective evaluation of health-related 
quality of life in Hong Kong Chinese patients 
with chronic non-cancer pain. Hong Kong Med 
J 2005; 11: 174-180.
[17] McHorney CA, War Jr JE, Lu JR and Sherbourne 
CD. The MOS 36-item Short-Form Health Sur-
vey (SF-36): III. Tests of data quality, scaling 
assumptions, and reliability across diverse pa-
tient groups. Med Care 1994; 40-66.
[18] Chang CH, Wright BD, Cella D and Hays RD. 
The SF-36 physical and mental health factors 
were confirmed in cancer and HIV/AIDS pa-
tients. J Clinical Epidemiol 2007; 60: 68-72.
[19] Huixu X, Qianbin W, Qingsong Y, Changxie W 
and Li L. Application of K/Sr co-doped calcium 
polyphosphate bioceramic as scaffolds for 
bone substitutes. J Mater Sci Mater Med 2012; 
23: 1033-1044. 
[20] Ernstsen L and Lillefjell M. Physical functioning 
after occupational rehabilitation and returning 
to work among employees with chronic muscu-
loskeletal pain and comorbid depressive symp-
toms. J Multidiscip Healthc 2014; 7: 55-63.
[21] Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K, 
Yano A, Fujii Y, Iwai A, Kageyama Y and Kihara 
K. Glucocorticoids suppress tumor angiogene-
sis and in vivo growth of prostate cancer cells. 
Clin Cancer Res 2006; 12: 3003-3009.
[22] Gu Q, Shi X, Yin P, Gao P, Lu X and Xu G. Analy-
sis of catecholamines and their metabolites in 
adrenal gland by liquid chromatography tan-
dem mass spectrometry. Anal Chim Acta 2008; 
609: 192-200.
